image
Alnylam Pharmaceuticals, Inc. ALNY
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
BALANCE SHEET
4.24 B ASSETS
10.71%
Growth Rates
1Year 10.71%
3Years 5.19%
5Years 12.10%
7Years 11.37%
10Years 14.66%
4.17 B LIABILITIES
3.02%
Growth Rates
1Year 3.02%
3Years 10.95%
5Years 34.26%
7Years 51.45%
10Years 40.09%
67.1 M EQUITY
130.41%
Growth Rates
1Year 130.41%
3Years -51.50%
5Years -45.83%
7Years -37.33%
10Years -23.17%
BALANCE SHEET DECOMPOSITION
Balance Sheet Alnylam Pharmaceuticals, Inc.
image
Current Assets 3.3 B
Cash & Short-Term Investments 2.69 B
Receivables 405 M
Other Current Assets 195 M
Non-Current Assets 945 M
Long-Term Investments 0
PP&E 694 M
Other Non-Current Assets 251 M
Current Liabilities 1.19 B
Accounts Payable 88.4 M
Short-Term Debt 41.9 M
Other Current Liabilities 1.06 B
Non-Current Liabilities 2.99 B
Long-Term Debt 0
Other Non-Current Liabilities 2.99 B

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
ASSETS
Cash & Cash Equivalents 127.1 812.7 866.4 820.0 496.6 547.2 420.1 645.4 193.6 1 281.0 881.9 53.2 51.4 70.2 74.6 137.5 191.8 105.2 128.0 15.8 20.3 23.2 15.5
Short Term Investments 1 728.1 1 626.7 1 326.0 1 615.6 1 377.8 989.0 664.0 1 045.3 433.2 51.4 94.6 192.7 71.4 76.2 158.5 143.9 238.6 350.4 89.3 64.2 25.8 0 0
Receivables 405.3 327.8 238.0 198.6 102.4 43.0 18.8 34.0 23.3 8.3 39.9 4.2 0.1 1.5 14.1 6.0 0 5.0 3.8 0.8 1.2 0 0
Inventory 78.5 89.1 129.0 122.7 92.3 56.3 24.1 1 1 1 0 1 0 (142.2) (226.2) 0 0 0 0 0 0 0 0
Other Current Assets 117.0 126.4 132.9 88.1 625.5 80.3 73.7 40.1 21.7 16.6 19.5 7.8 2.6 4.2 6.9 6.1 9.3 2.9 1.7 1.7 1.0 1.0 42 K
Total Current Assets 3 295.3 2 982.7 2 692.2 2 868.8 2 159.8 1 733.9 1 209.3 1 782.8 989.2 1 358.7 1 026.2 358.6 229.0 266.4 370.9 293.5 442.2 463.6 222.8 82.4 48.2 24.2 15.5
PP&E 693.9 725.8 738.6 733.6 706.5 646.4 320.7 181.9 114.6 27.8 21.7 16.4 19.8 14.6 18.3 18.3 19.2 13.8 12.2 10.6 11.7 4.8 0.5
Intangible Assets 0 697.8 264.6 0 0 0 0 0 0 0 0 0 0 0.3 0.4 0.6 0.8 1.0 1.9 2.5 3.4 3.9 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 (2 559.4) 40.9 40.7 14.8 44.8 30.0 9.0 251.8 279.8 45.5 38.7 0.6 3.6 6.4 1.6 0 0 0 0 0 0
Other Long Term Assets 133.9 (576.4) 115.5 0 500.0 0 0 0 150.0 (251.8) 279.8 0 0 115.0 120.4 152.0 85.5 15.5 3.1 2.9 2.8 2.4 66 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 4 240.0 3 829.9 3 546.4 3 643.3 3 407.1 2 395.1 1 574.8 1 994.7 1 262.8 1 386.5 1 079.6 420.5 287.5 281.9 393.3 481.4 554.7 493.8 240.0 98.3 66.1 35.2 16.1
LIABILITIES
Accounts Payable 88.4 55.5 98.1 73.4 52.0 49.9 59.7 28.4 54.5 16.8 15.1 5.9 4.4 5.8 9.3 12.5 2.6 3.8 4.1 2.0 0.9 1.5 0.7
Short Term Debt 41.9 96.5 82.3 77.6 50.2 27.7 0 0 0 0 0 0 0 0 0 0 0 2.4 3.2 1.9 0.8 0.6 0
Other Current Liabilities 1 000.5 713.0 545.5 395.2 355.9 197.2 116.3 74.2 43.7 28.8 55.3 15.3 12.5 12.8 11.1 9.8 10.9 11.7 4.5 3.9 3.9 1.4 2.0
Total Current Liabilities 1 186.3 967.8 767.9 1 191.3 1 128.0 956.4 242.8 198.3 192.6 121.8 143.3 150.2 153.5 18.1 231.5 110.7 99.5 82.1 22.9 18.5 6.6 3.8 2.7
Long Term Debt 0 2 586.1 2 530.3 2 108.1 484.3 552.3 30.0 30.0 150.0 0 0 0 0 0 0 0 0 3.0 5.9 5.5 6.4 1.3 0
Deferred Tax Income 0 0 0 (152.4) (225.1) 0 (5.4) (47.4) (52.5) 0 31.7 0 0 0 0 0 0 (204.1) (6.8) (10.1) (4.1) 0 0
Other Liabilities 2 986.6 308.4 212.6 99.0 1 096.1 (266.8) 62.9 11.0 11.5 6.7 5.0 2.9 4.2 0.7 3.0 2.8 3.0 5.5 3.2 0 0 56.7 18.1
Total Liabilities 4 172.9 4 050.5 3 704.6 3 055.1 2 390.8 956.4 272.8 228.3 342.6 121.8 143.3 150.2 153.5 163.9 235.0 303.4 352.6 294.6 38.8 36.6 20.0 61.9 20.8
EQUITY
Common Stock 1.3 1.3 1.2 1.2 1.2 1.1 1.0 1.0 0.9 0.9 0.8 0.6 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.2 0 0
Retained Earnings 0 (7 009.6) (6 569.3) (5 438.2) (4 585.4) (3 727.1) (2 841.0) (2 147.7) (1 656.8) (1 246.7) (956.6) (596.2) (507.0) (401.0) (343.3) (299.8) (252.2) (226.0) (140.5) (105.9) (63.0) (29.5) (4.5)
Other Accumulative Comprehensive Income/Loss 0 (23.4) (44.7) (33.3) (43.6) (36.5) (33.2) (34.4) (33.4) 4.4 48.8 19.7 15.7 (0.2) 0.7 0.7 1.2 0.3 0.6 (2.6) (3.3) (4.6) (0.2)
Total Equity 67.1 (220.6) (158.2) 588.2 1 016.2 1 438.7 1 302.0 1 766.4 920.2 1 264.7 936.3 270.3 134.1 118.0 158.2 178.0 202.1 199.2 201.2 61.8 46.1 (26.7) (4.6)
Total Liabilities and Equity 4 240.0 3 829.9 3 546.4 3 643.3 3 407.1 2 395.1 1 574.8 1 994.7 1 262.8 1 386.5 1 079.6 420.5 287.5 281.9 393.3 481.4 554.7 493.8 240.0 98.3 66.1 35.2 16.1
SHARES OUTSTANDING
Common Shares Outstanding 128.6 124.9 121.7 118.5 115.0 109.3 100.6 90.6 85.6 84.0 74.3 61.6 50.3 42.4 42.0 41.6 41.1 38.7 31.9 21.9 11.9 0.9 0.3